Bird & Bird Health

News and updates from @twobirds' Life Sciences & Healthcare group.

[Bird & Bird Health @twobirdshealth]

🩺 What's the latest on Digital Health law in the UK? From regulatory issues around data use, software as a medical device, through to the role of AI and the associated legal considerations - it's all in the UK Chapter of the @ICLG_GLG's Digital Health! https://t.co/1yT0VYZFXP

[Bird & Bird Health @twobirdshealth]

In our latest BioTalk article, we dive deeper into the introduction of an EU-wide procedure for obtaining authorisation for #SoHO preparations, and the potential issues and challenges that could arise from this: https://t.co/FSlWYZT0el

[Bird & Bird Health @twobirdshealth]

The HMA-EMA Big Data Steering Group's multi-annual #AI workplan - what key areas does it focus on to facilitate the development and use of responsible and beneficial AI? Check out our latest article on BioTalk to find out: https://t.co/niaobXky9z

[Bird & Bird Health @twobirdshealth]

Sally Shorthose, Pieter Miguel Erasmus and Max Gross have written the UK chapter for @thelegal500 Pharmaceutical Advertising Country Comparative Guide 2023! Click here to find out more and access: https://t.co/Dx9YqCInvB

[Bird & Bird Health @twobirdshealth]

Artificial intelligence in healthcare - what’s new? The WHO has published regulatory considerations on #AI for healthcare, with aims to promote international collaboration in AI regulations and standards in #healthcare. Click here to learn more: https://t.co/7grJrgXcVg

[Bird & Bird Health @twobirdshealth]

According to a common quip in the U.S., they innovate on the technology front and the Europeans innovate on the regulatory front. In this article on BioTalk, our team explore the contrasting approaches to #AI in drug development across the Atlantic: https://t.co/ypGFkhPjbZ

[Bird & Bird Health @twobirdshealth]

Click here to read our latest article on BioTalk, where we discuss the impact of #environmental regulations on the #healthcare sector, highlight the extension of extended producer responsibility, and more: https://t.co/APVVlJN6TU

[Bird & Bird Health @twobirdshealth]

Can virtue afford to flirt with legality? The Royal Decree of 13 September 2023, which establishes specific regulations for #PublicProcurement concerning biological medicines, opens the door for compulsory tendering when biosimilars enter the market: https://t.co/GpUwV5U8XE

[Bird & Bird Health @twobirdshealth]

Data, drugs, devices… Join us for our #DigitalHealth event in Amsterdam on 9 November! We’re excited to be joined by special guest speakers from @GSK, M Ventures and Nostics, alongside our international team of life sciences and tech specialists. Sign up: https://t.co/vOqPgxRhzY

[Bird & Bird Health @twobirdshealth]

#Psychedelics have been under investigation by academics, clinicians and pharmaceutical companies for some time and interest in this area shows no sign of slowing down. We look at the latest initiative in the US and the state of play in other countries: https://t.co/rAAJc8nKim

[Bird & Bird Health @twobirdshealth]

Check out our latest article in European Health & Pharmaceutical Law Review, assessing the proposed Regulation on safety and quality of human substances. Learn about the challenges and potential impact on the blood, tissues and cells industry here: https://t.co/BQMpEVcp3D

[Bird & Bird Health @twobirdshealth]

A proposed reform aims to replace current legislation on orphan medicinal products, addressing the needs of patients and the pharmaceutical sector. Learn about the key changes in the new regulation in our latest BioTalk article here: https://t.co/zHRJzlIcLZ

[Bird & Bird Health @twobirdshealth]

A new directive on medicinal products for human use has been proposed, strengthening the requirements for the environmental risk assessment (ERA) and extending the scope of the ERA to cover new protection goals. Click here to read more on BioTalk: https://t.co/oRIdBj04d4

[Bird & Bird Health @twobirdshealth]

We have put together an overview of the regulatory legislation concerning veterinary medicine, summarising national developments and legal frameworks regarding the advertising of veterinary medicinal products in several EU countries and the UK. Read more: https://t.co/kWt3SCPiTQ

[Bird & Bird Tech Comms @twobirdstech]

We're proud to sponsor @IrishMedtech 'Meeting of Minds' 29-30 May. Preceding the @medtecheurope #MTF2023, this event will offer unmissable networking opportunities, and the latest trends on healthtech innovation. Find out more: WhereDigitalHealthThrives https://t.co/3PY7gLr0Zr

[Bird & Bird Health @twobirdshealth]

The EU has ambitious plans for the European pharmaceutical industry. Our latest article covers the European Commission's long-awaited proposal for the revision of the pharmaceutical legislative framework. Click here: https://t.co/JtgCgwI8Mp

[Bird & Bird Health @twobirdshealth]

The Dutch Ministry of Health, Welfare and Sport has announced a new policy rule for the online prescription of medication, which came into force in April 2023. Click here to read more on BioTalk: https://t.co/QtMxU3ydff

[Bird & Bird Health @twobirdshealth]

Marketing or medicine: making health claims on products is highly regulated and subject to strict requirements. Click here to learn more about the conditions that must be met for specific and general health claims in the UK: https://t.co/vm0YstCL7Y

[Bird & Bird Health @twobirdshealth]

Following the coming into force of the Windsor Agreement on 25 March 2023, our team takes a look at what this means in practice for the UK pharmaceutical industry. Click here to read more on BioTalk: https://t.co/9mIiMctRi6

[Bird & Bird Health @twobirdshealth]

Read our latest article on BioTalk, discussing the government's recent consultation on proposals intended to improve the UK’s clinical trials legislation. Click here to read more: #ClinicalTrials https://t.co/NYCeh47eZ5